Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.210
+0.030 (2.54%)
At close: Apr 9, 2025, 4:00 PM
1.286
+0.076 (6.31%)
Pre-market: Apr 10, 2025, 4:06 AM EDT

Autolus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
10.121.76.362.331.72
Upgrade
Revenue
10.121.76.362.331.72
Upgrade
Revenue Growth (YoY)
496.00%-73.30%172.96%35.86%-41.02%
Upgrade
Cost of Revenue
141.02122.31117.35110.84134.89
Upgrade
Gross Profit
-130.9-120.62-110.99-108.51-133.17
Upgrade
Selling, General & Admin
109.8954.9131.931.8734.97
Upgrade
Operating Expenses
109.8954.9131.931.8734.97
Upgrade
Operating Income
-240.79-175.53-142.89-140.37-168.15
Upgrade
Interest Expense
-9.29-45.07-8.91-1.11-
Upgrade
Interest & Investment Income
32.3613.511.710.260.54
Upgrade
Currency Exchange Gain (Loss)
-0.992.641.8-2.3-0.2
Upgrade
Other Non Operating Income (Expenses)
0.320.220.340.161.55
Upgrade
EBT Excluding Unusual Items
-218.4-204.23-147.95-143.36-166.26
Upgrade
Gain (Loss) on Sale of Assets
-0.22-3.79-0.52-0.68-
Upgrade
Asset Writedown
-0.41-0.38---
Upgrade
Other Unusual Items
-0.1--0.12-
Upgrade
Pretax Income
-219.13-208.4-148.57-142.04-166.26
Upgrade
Income Tax Expense
1.53-0.020.270.06-24.16
Upgrade
Net Income
-220.66-208.38-148.84-142.1-142.09
Upgrade
Net Income to Common
-220.66-208.38-148.84-142.1-142.09
Upgrade
Shares Outstanding (Basic)
255174957252
Upgrade
Shares Outstanding (Diluted)
255174957252
Upgrade
Shares Change (YoY)
46.69%83.11%31.78%39.81%19.72%
Upgrade
EPS (Basic)
-0.86-1.20-1.57-1.97-2.76
Upgrade
EPS (Diluted)
-0.86-1.20-1.57-1.97-2.76
Upgrade
Free Cash Flow
-228.35-156.57-123.15-126.72-132.44
Upgrade
Free Cash Flow Per Share
-0.90-0.90-1.30-1.76-2.57
Upgrade
Operating Margin
-2379.34%-10337.34%-2246.74%-6024.64%-9804.37%
Upgrade
Profit Margin
-2180.45%-12272.26%-2340.24%-6098.54%-8285.36%
Upgrade
Free Cash Flow Margin
-2256.38%-9221.02%-1936.31%-5438.54%-7722.39%
Upgrade
EBITDA
-233.07-168.96-135.54-132.01-162.58
Upgrade
D&A For EBITDA
7.726.577.368.375.57
Upgrade
EBIT
-240.79-175.53-142.89-140.37-168.15
Upgrade
Revenue as Reported
10.121.7---
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q